Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,155 | 94 | 1,517 | 869 | 281 |
| Receivables | 750 | 1,585 | 1,559 | 370 | 781 |
| Other current assets | 0 | 21 | 426 | 657 | 101 |
| TOTAL | $4,135 | $1,745 | $3,548 | $1,935 | $1,224 |
| Non-Current Assets | |||||
| Investments And Advances | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $32 | $32 | $32 | $32 | $32 |
| Total Assets | $4,167 | $1,777 | $3,580 | $1,966 | $1,256 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 972 | 1,598 | 1,552 | 579 | 2,167 |
| TOTAL | $972 | $2,622 | $1,995 | $1,261 | $2,272 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 0 | 22 | 443 | 682 | 105 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 19,319 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $19,319 |
| Total Liabilities | $972 | $2,622 | $1,995 | $1,261 | $21,591 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 152,086 | 151,560 | 135,850 | 134,550 | 62,732 |
| Common Shares | 1,520 | 1,359 | 1,359 | 1,346 | 627 |
| Retained earnings | -190,188 | -186,630 | -184,002 | -183,922 | -180,714 |
| Other shareholders' equity | 0 | 5 | 5 | 5 | 5 |
| TOTAL | $3,195 | $-845 | $1,585 | $705 | $-20,335 |
| Total Liabilities And Equity | $4,167 | $1,777 | $3,580 | $1,966 | $1,256 |